<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
(RULE 13D-102)
UNDER
THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )1
NEXMED, INC.
--------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $0.001 PER SHARE
--------------------------------------------------------------------------------
(Title of Class of Securities)
652903105
--------------------------------------------------------------------------------
(CUSIP Number)
JUNE 21, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
/ / Rule 13d-1(b)
/X/ Rule 13d-1(c)
/ / Rule 13d-1(d)
------------------
1 The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which would
alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP No. 652903105 13G Page 2 of 4 Pages
---------
-------------------------------------------------------------------------------
(1) Names of Reporting Persons.
I.R.S. Identification Nos. of above persons (entities only).
Vergemont International Limited/d/b/a/NexMed Asian Pacific Limited
-------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group (See Instructions) (b) / /
Not Applicable
-------------------------------------------------------------------------------
(3) SEC Use Only
-------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
Turks & Caicos Islands
-------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 2,000,000
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With: 0
--------------------------------------------------
(7) Sole Dispositive Power
2,000,000
--------------------------------------------------
(8) Shared Dispositive Power
0
-------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
2,000,000
-------------------------------------------------------------------------------
(10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions) / /
-------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
9.2%
-------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions)
CO
-------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
page 3 of 4 pages
<PAGE>
SCHEDULE 13G
ITEM 1
(a) NAME OF ISSUER. NexMed, Inc.
(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICE: 350 Corporate
Boulevard Robbinsville, New Jersey 08691.
ITEM 2
(a) NAME OF PERSON FILING. This Schedule 13G is being filed for
Vergemont International Limited d/b/a/ NexMed Asian Pacific
Limited ("Vergemont").
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE. The principal business
office of Vergemont is Room 2208, Windsor House, 311
Gloucester Road, Causeway Bay, Hong Kong.
(c) CITIZENSHIP. Vergemont is a Turks & Caicos Island Company.
(d) TITLE OF CLASS OF SECURITIES. Common Stock, par value $0.001
per share ("Common Stock").
(e) CUSIP NUMBER. 652903105.
ITEM 3 NOT APPLICABLE.
ITEM 4 OWNERSHIP.
(a) AMOUNT BENEFICIALLY OWNED. As of the date hereof, Vergemont
owned 2,000,000 shares of Common Stock.
(b) PERCENT OF CLASS. The shares of Common Stock held by Vergemont
represent approximately 9.2% of the Common Stock
outstanding.
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) sole power to vote or to direct the vote: 2,000,000
(ii) shared power to vote or to direct the vote: -0-
(iii) sole power to dispose or to direct the disposition of:
2,000,000
(iv) shared power to dispose or to direct the disposition of:
-0- .
ITEM 5 OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
Not Applicable.
ITEM 6 OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
Not Applicable.
<PAGE>
ITEM 7 IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
Not Applicable.
ITEM 8 IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
Not Applicable.
ITEM 9 NOTICE OF DISSOLUTION OF GROUP.
Not Applicable.
ITEM 10 CERTIFICATION.
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were acquired and are not held for the
purpose of or with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in connection
with or as a participant in any transaction having that purpose or effect.
SIGNATURES
DATE: June 29, 2000
VERGEMONT INTERNATIONAL LIMITED
By: /s/ Tsu Huang Wu
----------------------------
Name: Tsu Huang Wu
Title: Managing Director
page 4 of 4 pages
